Caramiphen

Caramiphen
Clinical data
Trade names	Carafen
ATC code	None;
Identifiers
	IUPAC name 2-(Diethylamino)ethyl 1-phenylcyclopentanecarboxylate;
CAS Number	77-22-5;
PubChem CID	6472;
ChemSpider	6228;
ChEMBL	ChEMBL61946;
CompTox Dashboard (EPA)	DTXSID0022729 ;
ECHA InfoCard	100.000.922
Chemical and physical data
Formula	C18H27NO2
Molar mass	289.413 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCCN(CC)CC)C2(c1ccccc1)CCCC2;
	InChI InChI=1S/C18H27NO2/c1-3-19(4-2)14-15-21-17(20)18(12-8-9-13-18)16-10-6-5-7-11-16/h5-7,10-11H,3-4,8-9,12-15H2,1-2H3; Key:OFAIGZWCDGNZGT-UHFFFAOYSA-N;

Caramiphen is an anticholinergic drug used in the treatment of Parkinson's disease.^[1] In combination with phenylpropanolamine it is used as a cough suppressant and nasal decongestant to treat symptoms associated with respiratory illnesses such as cold, allergies, hay fever, and sinusitis.^[2]

Synthesis

^ "Caramiphen". drugs.com. Retrieved 26 September 2012.
^ "Caramiphen with phenylpropanolamine-oral, Ordrine AT, Rescaps-D, Tuss Vernade, Tusso-Gest". medicine.net. Retrieved 26 September 2012.
^ V. Petrow, 0. Stephenson, and A. M. Wild, U.S. patent 2,885,404 (1959).

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.